Incir Pharma Private Limited
About Incir Pharma Private Limited
Data last updated:
Incir Pharma Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 27 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2020PTC350883. Its GSTIN is 27AAFCI9172F1ZC (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sabir Ali Usman Ali Sayyed and Tanveer Ahmed Musa Shaikh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No. 180 Mangesh Traders K U Samitee Mkt Yard, Panvel, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.2 Lakh. For the same year it recorded a net loss of ₹79,665 (net margin -24.9%) and EBITDA of -₹79,665 (EBITDA margin -24.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGala No. 180 Mangesh Traders K U Samitee Mkt Yard, Panvel, Maharashtra, India – 410206
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Incir Pharma Private Limited
The main business activity of Incir Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Incir Pharma Private Limited FY 2025 filings available
Incir Pharma Private Limited reported revenue of ₹3.2 Lakh for FY 2025.
Financial Statement Summary of Incir Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹79,665 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹79,665 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Incir Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -24.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Incir Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Incir Pharma Private Limited
Incir Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Moosapet Fed Farmer Producer Company Limited | ₹3.23 Lakh (FY 2025) | •••• | •••• | -66.0% | •••• | Mahabubnagar, Telangana, India |
| Worldwealth Dealers Private Limited | ₹3.21 Lakh (FY 2025) | •••• | •••• | -100.0% | •••• | Kolkata, West Bengal, India |
| Annova India Electronic Private Limited | ₹3.21 Lakh (FY 2025) | •••• | •••• | -88.0% | •••• | Pune, Maharashtra, India |
| Sri Puri Jagannadh Hatcheries Private Limited | ₹3.2 Lakh (FY 2025) | •••• | •••• | •••• | Tuni, Andhra Pradesh, India | |
| Orvillagold Private Limited | ₹3.2 Lakh (FY 2024) | •••• | •••• | 162.0% | •••• | Thane, Maharashtra, India |
| Incir Pharma Private Limited this company | ₹3.2 Lakh (FY 2025) | •••• | •••• | •••• | Panvel, Maharashtra, India | |
| TSQ Multi Services Private Limited | ₹3.2 Lakh (FY 2025) | •••• | •••• | -89.0% | •••• | Nagpur, Maharashtra, India |
| Pati Agrofed Farmers Producer Company Limited | ₹3.2 Lakh (FY 2025) | •••• | •••• | -91.0% | •••• | Barwani, Madhya Pradesh, India |
| K & R Banijya Private Limited | ₹3.19 Lakh (FY 2025) | •••• | •••• | -68.0% | •••• | Dinhata, West Bengal, India |
| Shuubharambh Events Private Limited | ₹3.19 Lakh (FY 2024) | •••• | •••• | 153.0% | •••• | Sangli, Maharashtra, India |
| Kelbuzz Trading Private Limited | ₹3.19 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Incir Pharma by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Incir Pharma Private Limited
Incir Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sabir Ali Usman Ali Sayyed Also directs: Zeytin Pharma Private Limited | Director | 27 Nov 2020 | 5 Years 10 Months | Current |
| Tanveer Ahmed Musa Shaikh | Director | 27 Nov 2020 | 5 Years 10 Months | Current |
| Shakiloddin Rahimoddin Kazi | Director | 27 Nov 2020 | 5 Years 10 Months | Current |
Ownership and Shareholding of Incir Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Incir Pharma Private Limited
Incir Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Incir Pharma Private Limited
Incir Pharma Private Limited has a workforce of 0 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Incir Pharma Private Limited
Incir Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Sabir Ali Usman Ali Sayyed was appointed as Director on 27 Nov 2020.
Credit Ratings, Litigation & Regulatory Alerts for Incir Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Incir Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Incir Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Incir Pharma Private Limited
Incir Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI9172F1ZC | Maharashtra | Active | 29 Sep 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Incir Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Incir Pharma Private Limited
Incir Pharma is an active private limited company based in Panvel, Maharashtra, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 27 November 2020 (6+ years old) and is registered under CIN U24110MH2020PTC350883.
Incir Pharma reported revenue of ₹3.2 Lakh for FY 2025.
Incir Pharma has 3 current directors:
- Sabir Ali Usman Ali Sayyed - Director
- Tanveer Ahmed Musa Shaikh - Director
- Shakiloddin Rahimoddin Kazi - Director
Incir Pharma reported a net loss of ₹79,665 (net margin -24.9%) and EBITDA of -₹79,665 (EBITDA margin -24.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Incir Pharma is 27AAFCI9172F1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Incir Pharma is U24110MH2020PTC350883. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incir Pharma was incorporated on 27 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Incir Pharma by revenue are Moosapet Fed Farmer Producer Company Limited, Worldwealth Dealers Private Limited, Annova India Electronic Private Limited, Sri Puri Jagannadh Hatcheries Private Limited, Orvillagold Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Sabir Ali Usman Ali Sayyed was appointed as Director on 27 Nov 2020. Shakiloddin Rahimoddin Kazi was appointed as Director on 27 Nov 2020. Tanveer Ahmed Musa Shaikh was appointed as Director on 27 Nov 2020.
The registered office of Incir Pharma is at Gala No. 180 Mangesh Traders K U Samitee Mkt Yard, Panvel, Maharashtra, India – 410206.
Incir Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.